Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds Pharmaceuticals US will go public soon. The estimated IPO date is March 3, 2025.

IPO Price Range

$4.00 - $5.00

Shares Offered

4,500,000

Deal Size

$20.25M

APUS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	57	-	-
Enterprise Value	57	-	-
Debt / Equity Ratio	-0.56	8.37	-0.92
Debt / EBITDA Ratio	-0.29	-0.36	-1.03
Debt / FCF Ratio	-0.38	-0.43	-1.47
Quick Ratio	0.13	3.33	0.02
Interest Coverage	-22.67	-24.70	-21.95
Return on Equity (ROE)	199.28%	-2440.13%	93.70%
Return on Assets (ROA)	-	-184.25%	-10835.62%
Return on Capital (ROIC)	433.29%	-250.18%	1193.02%
Return on Capital Employed (ROCE)	279.15%	-250.18%	203.93%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).